Non-viral gene therapy for neurological diseases, with an emphasis on targeted gene delivery

This review describes the potential of targeting non-viral vectors to deliver genes into the central nervous system with an emphasis on antibodies to specific receptors as delivery agents (immunogenes). Schematic shows method of entry of immunogenes into cells and processes leading to protein expression or silencing.314